These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16550148)

  • 1. [Ezetimibe with statins].
    Jublanc C; Giral P; Turpin G
    Presse Med; 2006 Mar; 35(3 Pt 2):487-94. PubMed ID: 16550148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LDL reduction: how low should we go and is it safe?
    Robinson JG
    Curr Cardiol Rep; 2008 Nov; 10(6):481-7. PubMed ID: 18950559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezetimibe and fenofibrate combination therapy for mixed hyperlipidemia.
    Moon YS; Chun P; Chung S
    Drugs Today (Barc); 2007 Jan; 43(1):35-45. PubMed ID: 17315051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezetimibe is effective in the treatment of persistent hyperlipidemia of renal allograft recipients.
    Savvidaki E; Koukoulaki M; Benou A; Roumeliotou M; Fourtounas C; Kalliakmani P; Papachristou E; Vlachojannis JG; Goumenos D
    Clin Nephrol; 2011 Feb; 75(2):107-12. PubMed ID: 21255539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
    Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
    Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R; Goldberg AC
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin and ezetimibe combination therapy in cardiovascular disease.
    Dembowski E; Davidson MH
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):183-8. PubMed ID: 19262375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antilipemic agents in combined therapy].
    Márk L; Császár A
    Orv Hetil; 2002 Aug; 143(34):1973-8. PubMed ID: 12422650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Optimization of cholesterol reduction principles and clinical results of dual inhibition].
    von Hodenberg E
    Internist (Berl); 2005 May; 46 Suppl 1():S18-23. PubMed ID: 15834540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy for dyslipidemia: safety and regulatory considerations.
    Davidson MH
    Am J Cardiol; 2002 Nov; 90(10B):50K-60K. PubMed ID: 12467940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal sterol transporters and cholesterol absorption inhibition.
    Davis HR; Tershakovec AM; Tomassini JE; Musliner T
    Curr Opin Lipidol; 2011 Dec; 22(6):467-78. PubMed ID: 22101558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-lowering effects of ezetimibe and simvastatin in combination.
    Ijioma N; Robinson JG
    Expert Rev Cardiovasc Ther; 2011 Feb; 9(2):131-45. PubMed ID: 21453210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-line treatments for dyslipidemia in patients at risk of cardiovascular disease.
    Kondo Y; Hamai J; Nezu U; Shigematsu E; Kamiko K; Yamazaki S; Yoshii T; Takahashi M; Takano T; Kawasaki S; Yamada M; Yamakawa T; Terauchi Y
    Endocr J; 2014; 61(4):343-51. PubMed ID: 24452015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ezetimibe: cholesterol lowering and beyond.
    Bays HE; Neff D; Tomassini JE; Tershakovec AM
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):447-70. PubMed ID: 18402536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of combination therapy for dyslipidemia: a lipid clinic approach.
    Brown AS
    Am J Cardiol; 2002 Nov; 90(10B):44K-49K. PubMed ID: 12467939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ezetimibe plus fenofibrate: a new combination therapy for the management of mixed hyperlipidaemia?
    Farnier M
    Expert Opin Pharmacother; 2007 Jun; 8(9):1345-52. PubMed ID: 17563268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical efficacy of ezetimibe and combined use with statins].
    Pascual Izuel JM; Rodilla Sala E; Sánchez Juan C
    Rev Clin Esp; 2005 Oct; 205(10):496-8. PubMed ID: 16238961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of ezetimibe for treatment of dyslipidemia after heart transplantation.
    Crespo-Leiro MG; Paniagua MJ; Marzoa R; Grille Z; Naya C; Flores X; Rodriguez JA; Mosquera V; Franco R; Castro-Beiras A
    Transplant Proc; 2008 Nov; 40(9):3060-2. PubMed ID: 19010194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ezetimibe (Ezetrol)].
    Scheen AJ
    Rev Med Liege; 2004 Apr; 59(4):246-50. PubMed ID: 15182038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.